CAF.ASX
Centrepoint Alliance Ltd
https://www.marketindex.com.au/asx/caf/financials
Annual Financial Summary
Print Financials
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
Profitability
NPAT ($)
6,339,000
6,492,000
NPAT Margin
2.36%
3.33%
Abnormals ($)
(54,000)
(1,100,000)
NPAT before Abnormals ($)
6,393,000
7,592,000
Return on Equity (ROE)
20.59%
26.92%
Return on Assets (ROA)
13.48%
15.53%
Valuation
PE Ratio
7.65
7.40
PE Relative to Market
55.4%
39.2%
Price to Book
1.42
2.01
Price to Cash Flow
6.76
12.85
Shares Outstanding (M)
196.88
195.88
Market Cap ($M)
$44.30
$56.81
Enterprise Value ($M)
$29.49
$44.58
Performance
Total Shareholder Return
-15.8%
44.0%
Relative to Market
-30.6%
51.5%
Per Share
Earnings (EPS Adjusted)
2.92
3.35
Earnings (with Abnormals)
2.94
3.92
Cash Flow
1.90
3.80
Cash
0.08
0.08
Net Tangible Assets
0.07
0.05
Book Value
0.16
0.14
Share Price
$0.23
$0.29
Liquidity
Quick Ratio
1.70
1.33
Current Ratio
1.70
1.33
Efficiency
Asset Turnover
5.63
4.61
Inventory Turnover
-
-
Working Capital Turnover
(48.96)
(25.57)
Dividends
DPS (c)
3.00
2.50
Dividend yield
13.33%
8.62%
Franking
100%
100%
Gross DPS (c)
4.29
3.57
Gross Dividend Yield
19.05%
12.32%
Payout Ratio
102%
64%
Member Content
Source:
Annual Financial Income Statement
Print Financials
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
Revenue from Operations
Investment Income
400,000
53,000
Other Income
273,447,000
228,475,000
Expenses
(267,233,000)
(225,958,000)
Profit / Loss before income tax
6,668,000
3,670,000
Tax Expense
(275,000)
3,922,000
NPAT before Abnormals
6,393,000
7,592,000
Abnormals
(54,000)
(1,100,000)
Abnormals Tax
-
-
Net Abnormals
(54,000)
(1,100,000)
Outside Equity
-
-
Preference Dividends
-
-
Reported NPAT after Abnormals
6,339,000
6,492,000
EQUITY
Share End
196,881,889
195,881,889
Share Weighted
217,089,041
193,791,044
Ordinary Dividends
-
(2,938,231)
EPS Adjusted
29,400
39,200
EPS after Abs
29,200
33,500
Equity Profit / Loss
-
-
Member Content
Source:
Annual Financial Balance Sheet
Print Financials
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
CURRENT ASSETS
Cash and Cash Equivalents
15.61
14.74
Receivables
6.21
5.41
Investments
-
-
Other Current Assets
1.55
1.3
Total Current Assets
23.37
21.45
NON-CURRENT ASSETS
Investments
0.12
0.12
Property
-
-
Other Non-Current Assets
24.63
27.78
Total Non-Current Assets
24.74
27.89
TOTAL ASSETS
48.11
49.34
CURRENT LIABILITIES
Creditors
9.36
10.04
Provisions
3.94
5.56
Other Liabilities
0.49
0.51
TOTAL CURRENT LIABILITIES
13.78
16.12
NON-CURRENT LIABILITIES
Borrowings
0.32
2.01
Deferred Tax
2.43
2.43
Other Non-Current Liabilities
0.42
0.47
TOTAL NON-CURRENT LIABILITIES
3.16
4.91
TOTAL LIABILITIES
16.94
21.02
NET ASSETS
65.05
70.36
Total Equity Attr. to Holders
31.05
28.2
Outside Equity
0.12
0.12
TOTAL EQUITY
31.17
28.32
Member Content
Source:
Annual Financial Cash Flow
Print Financials
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
270.72
228.68
Payments
(266.39)
(220.83)
Funds from Operations
-
-
Dividends Received
-
-
Interest Received
-
-
Interest Paid
-
-
Tax Paid
-
-
Other Operating Cash
(0.2)
(0.55)
NET CASH FROM OPERATING ACTIVITIES
4.13
7.3
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
1.5
-
Payments
-
-
PP&E
(0.58)
(0.37)
Proceeds PP&E
-
-
Purchase Subsidiary
-
-
Proceeds Subsidiary
(0.11)
0.07
Loans Granted
-
-
Loans Repaid
-
-
Other Investing Cash
0.46
1.18
NET CASH FROM INVESTING ACTIVITIES
1.26
0.88
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
-
-
Proceeds from Borrowings
-
-
Borrowings
(0.57)
(0.61)
Dividends Paid
(3.93)
(3.9)
Other Financing Cash
(0.03)
(0.05)
NET CASH FROM FINANCING ACTIVITIES
(4.53)
(4.56)
NET CHANGE IN CASH
0.87
3.61
CASH AT START
14.74
11.13
Exchange Rate Adjustment
-
-
Other Cash Adjustment
-
-
CASH AT END
15.61
14.74
Member Content
Source: